Difficulty in differentiating liver injury from an immune checkpoint inhibitor from chemotherapy

This study investigated the potential of immune checkpoint inhibitors (ICIs) combined with chemotherapy as a promising treatment approach for malignancies. This report focuses on a patient with drug-induced liver injury (DILI) following the administration of chemotherapy and ICIs. A 63-year-old pati...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Shike Lou, Xiaoyin Wang, Fei Yuan, Gangde Zhao, Mingyang Feng, Yezhou Ding, Lanyi Lin, Kehui Liu, Xiaolin Wang, Wanqing Chi, Hui Wang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2024-08-01
coleção:	Frontiers in Pharmacology
Assuntos:	immune checkpoint inhibitors (ICIs) chemotherapy DILI combined therapy lung adenocarcinoma liver biopsy
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1453595/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!